Mary Palmen

2.0k total citations · 1 hit paper
23 papers, 1.7k citations indexed

About

Mary Palmen is a scholar working on Epidemiology, Immunology and Genetics. According to data from OpenAlex, Mary Palmen has authored 23 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Epidemiology, 12 papers in Immunology and 8 papers in Genetics. Recurrent topics in Mary Palmen's work include Microscopic Colitis (10 papers), Inflammatory Bowel Disease (8 papers) and Immune Cell Function and Interaction (5 papers). Mary Palmen is often cited by papers focused on Microscopic Colitis (10 papers), Inflammatory Bowel Disease (8 papers) and Immune Cell Function and Interaction (5 papers). Mary Palmen collaborates with scholars based in Netherlands, United States and United Kingdom. Mary Palmen's co-authors include E. P. van Rees, A. S. Peña, Levinus A. Dieleman, S. G. M. Meuwissen, Elisabeth Bloemena, Halil Akol, David D. Stephenson, Raymond E. Joseph, Michael A. Kamm and William J. Sandborn and has published in prestigious journals such as Gastroenterology, Journal of the American Society of Nephrology and European Journal of Immunology.

In The Last Decade

Mary Palmen

20 papers receiving 1.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Chronic experimental colitis induced by dextran sulphate sodium (DSS) is characterized by Th1 and Th2 cytokines

1998 963 citations Levinus A. Dieleman, Mary Palmen et al. Clinical & Experimental Immunology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Mary Palmen Netherlands	12	768	533	447	417	324	23	1.7k
Gary S. Tennyson United States	8	782 1.0×	779 1.5×	487 1.1×	381 0.9×	481 1.5×	10	2.1k
Andreas Lügering Germany	28	681 0.9×	960 1.8×	596 1.3×	697 1.7×	409 1.3×	58	2.6k
Mehmet Coskun Denmark	23	871 1.1×	572 1.1×	869 1.9×	335 0.8×	437 1.3×	41	2.1k
Katharina Gerlach Germany	14	583 0.8×	699 1.3×	807 1.8×	181 0.4×	265 0.8×	23	1.8k
Lawrence J. Saubermann United States	20	516 0.7×	842 1.6×	684 1.5×	383 0.9×	304 0.9×	38	2.0k
Mina T. Kitazume Japan	17	842 1.1×	1.4k 2.5×	625 1.4×	432 1.0×	436 1.3×	20	2.4k
Jakob Benedict Seidelin Denmark	28	984 1.3×	684 1.3×	666 1.5×	651 1.6×	560 1.7×	140	2.3k
Eva Martini Germany	13	382 0.5×	663 1.2×	1.0k 2.3×	216 0.5×	235 0.7×	19	1.7k
Imke Atreya Germany	26	1.0k 1.3×	1.4k 2.6×	671 1.5×	443 1.1×	427 1.3×	71	2.7k
Adrianus C. J. M. de Bruijn Netherlands	11	382 0.5×	332 0.6×	823 1.8×	178 0.4×	351 1.1×	13	1.6k

Countries citing papers authored by Mary Palmen

Since Specialization

Citations

This map shows the geographic impact of Mary Palmen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mary Palmen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mary Palmen more than expected).

Fields of papers citing papers by Mary Palmen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mary Palmen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mary Palmen. The network helps show where Mary Palmen may publish in the future.

Co-authorship network of co-authors of Mary Palmen

This figure shows the co-authorship network connecting the top 25 collaborators of Mary Palmen. A scholar is included among the top collaborators of Mary Palmen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mary Palmen. Mary Palmen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Teng, Y K Onno, et al.. (2022). FC054: Voclosporin for Lupus Nephritis: Results of the Two-Year Aurora 2 Continuation Study. Nephrology Dialysis Transplantation. 37(Supplement_3). 2 indexed citations

Menn‐Josephy, Hanni, Matt Truman, Mary Palmen, & Paola Mina‐Osorio. (2021). Voclosporin Is Effective in Achieving Complete Renal Response in Severe Lupus Nephritis. Journal of the American Society of Nephrology. 32(10S). 48–48. 1 indexed citations

Ding, Yanhua, Xiaoxue Zhu, Xiaojiao Li, et al.. (2020). Pharmacokinetic, Pharmacodynamic, and Safety Profiles of Ferric Carboxymaltose in Chinese Patients with Iron-deficiency Anemia. Clinical Therapeutics. 42(2). 276–285. 14 indexed citations

Palmen, Mary, et al.. (2014). P394 Pooled clinical trial analysis of MMX mesalazine safety: Focus on 4.8 g/d dose long-term exposure. Journal of Crohn s and Colitis. 8. S230–S230.

Paridaens, Kristine, et al.. (2012). P353 MMX® a mesalazine and long-term safety: A pooled analysis. Journal of Crohn s and Colitis. 6. S150–S150.

Kane, Sunanda V., Seymour Katz, Mazen M. Jamal, et al.. (2011). Strategies in maintenance for patients receiving long-term therapy (SIMPLE): A study of MMX mesalamine for the long-term maintenance of quiescent ulcerative colitis*. Inflammatory Bowel Diseases. 18(6). 1026–1033. 26 indexed citations

Paridaens, Kristine, et al.. (2011). Pooled Safety Analysis of Long-term MMX®,a Mesalamine Administration. Inflammatory Bowel Diseases. 17. S25–S25.

Kane, Sunanda V., et al.. (2010). W1328 MMX® Mesalamine 2.4g/Day Maintains Clinical Remission in Patients With Mild-to-Moderate Ulcerative Colitis, Irrespective of Prior Treatment. Gastroenterology. 138(5). S–700. 1 indexed citations

Knebel, William, Mary Palmen, James A. Dowell, & Marc R. Gastonguay. (2008). Population Pharmacokinetic Modeling of Epoetin Delta in Pediatric Patients With Chronic Kidney Disease. The Journal of Clinical Pharmacology. 48(7). 837–848. 7 indexed citations

10.

Wray, Heather, Richard J. Joseph, Mary Palmen, & David M. Pierce. (2008). Combined pharmacokinetic and scintigraphic analyses for the comparison of 5-ASA release profiles from MMX™ mesalamine and another delayed-release mesalamine formulation. Inflammatory Bowel Diseases. 14. S19–S20. 1 indexed citations

11.

D’Haens, Geert, Daan W. Hommes, L.G.J.B. Engels, et al.. (2006). Once daily MMX mesalazine for the treatment of mild‐to‐moderate ulcerative colitis: a phase II, dose‐ranging study. Alimentary Pharmacology & Therapeutics. 24(7). 1087–1097. 66 indexed citations

12.

Burg, Sjoerd H. van der, Anand G. Menon, Kees L. M. C. Franken, et al.. (2001). Long lasting p53-specific T cell memory responses in the absence of anti-p53 antibodies in patients with resected primary colorectal cancer. European Journal of Immunology. 31(1). 146–155. 52 indexed citations

13.

Palmen, Mary, et al.. (1998). Effects of Local Budesonide Treatment on the Cell-Mediated Immune Response in Acute and Relapsing Colitis in Rats. Digestive Diseases and Sciences. 43(11). 2518–2525. 12 indexed citations

14.

Dieleman, Levinus A., Mary Palmen, Halil Akol, et al.. (1998). Chronic experimental colitis induced by dextran sulphate sodium (DSS) is characterized by Th1 and Th2 cytokines. Clinical & Experimental Immunology. 114(3). 385–391. 963 indexed citations breakdown →

15.

Palmen, Mary, et al.. (1998). CD4+ T cells from 2,4,6-trinitrobenzene sulfonic acid (TNBS)-induced colitis rodents migrate to the recipient's colon upon transfer; down-regulation by CD8+ T cells. Clinical & Experimental Immunology. 112(2). 216–225. 15 indexed citations

16.

Rees, E. P. van, Mary Palmen, Frank R.W. van de Goot, B.A. Macher, & Levinus A. Dieleman. (1997). Leukocyte migration in experimental inflammatory bowel disease. Mediators of Inflammation. 6(2). 85–93. 2 indexed citations

17.

McDonald, Stuart A.C., Mary Palmen, E. P. van Rees, & Thomas T. MacDonald. (1997). Characterization of the mucosal cell‐mediated immune response in IL‐2 knockout mice before and after the onset of colitis. Immunology. 91(1). 73–80. 69 indexed citations

18.

Palmen, Mary, C Dijkstra, Marja B. van der Ende, A. S. Peña, & E. P. van Rees. (1995). Anti-CD11b/CD18 antibodies reduce inflammation in acute colitis in rats. Clinical & Experimental Immunology. 101(2). 351–356. 89 indexed citations

19.

Palmen, Mary, Marja B. van der Ende, A. S. Peña, & E. P. van Rees. (1994). Non-Lymphoid Cells in Acute and Chronic Experimental Inflammatory Bowel Disease. Advances in experimental medicine and biology. 355. 283–287. 1 indexed citations

20.

Jones, Simon R. M., Mary Palmen, & W.B. van Muiswinkel. (1993). Effects of inoculum route and dose on the immune response of common carp, Cyprinus carpio to the blood parasite, Trypanoplasma borreli. Veterinary Immunology and Immunopathology. 36(4). 369–378. 28 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact